The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,779.50
Bid: 1,779.50
Ask: 1,780.00
Change: -9.00 (-0.50%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,777.00
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: BG Group drags FTSE 100 lower, Syria concerns weigh

Mon, 09th Sep 2013 17:44

The FTSE 100 dropped into the red on Monday, pulling back after hitting a three-week high the previous session, as heavy falls from natural gas giant BG Group and ongoing concerns about Syria pressured stocks lower.London's benchmark index finished 16.59 points lower at 6,530.74, falling 0.25% from Friday's close of 6,547.33 which was its highest closing price since August 14th.Syria continues to be in focus this week ahead of a vote by US Congress over whether or not to proceed with a military attack after last month's alleged use of chemical weapons by Bashar Al-Assad's regime. Tensions at the G20 Summit escalated last week after Vladimir Putin said Russia would "assist" Syria if it was attacked by the US, just as President Barack Obama was trying to rally for support from global leaders for an intervention.Talks between US Secretary of State John Kerry and UK Foreign Secretary William Hague also caught the headlines this morning after Hague said the objectives and efforts of the US and UK "remain closely aligned". Kerry said that the relationship between the two countries was not affected by the UK's decision not engage in a military attack, but said that "the risk of not acting is greater than the risk of acting"."Despite the UK watching the Syria affair from the side-lines after the Prime Minister failed to secure parliamentary support for action, fallout from this vote will still be felt in the UK markets with oil prices and a potential flight to quality affecting both equity and Gilts," said Financial Sales Trader Alex Conroy.Uncertainty regarding Federal Reserve monetary policy also prompted traders to adopt a cautious approach in the aftermath of Friday's disappointing jobs report. A worse-than-expected rise in non-farm payrolls in August sparked speculation that the US central bank could hold off from tapering its quantitative easing (QE) programme until later on in the year. However, the unemployment rate fell last month from 7.4% to 7.3%.Chinese exports rise, Japan GDP revised upAsian markets performed well overnight after Chinese trade and inflation numbers brightened the third-quarter outlook for the world's second-largest economy. Chinese exports rose by a stronger-than-expected 7.2% in August and imports jumped by 7%, while the annual rate of consumer price inflation eased from 2.7% to 2.6%. Writing in Monday's Financial Times Chinese Premier Li Keqiang said that his country will stay the course on sustainable growth, by continuing to promote reforms, with an aim of meeting its 7.5% lower bound for gross domestic product (GDP) growth this year. Meanwhile, second-quarter GDP estimates in Japan were revised higher from 0.6% to 0.9%, as confidence grows in Prime Minister Shinzo Abe's so-called 'Abenomics'. While this was slightly lower than predictions, this data - along with the news that Tokyo will host the 2020 Olympics - gave the Nikkei 225 index a strong boost.FTSE 100: BG drops after cutting production guidanceOil and gas group BG was a heavy faller after lowering its 2014 production milestones due to the instability in Egypt, delays to the start-up of production in Norway and low natural gas prices in the US.Sugar and food group Tate & Lyle wasn't far behind after UBS downgraded the stock from 'neutral' to 'sell', saying that its current valuation is too high and does not reflect that "sucralose prices continue to decline as 'generic' competitors improve product quality and access greater scale".Food ingredients peer and retail group Associated British Foods was also lower despite saying a strong finish to the year from Primark will help it deliver adjusted operating profit ahead of expectations for the second half. Instead, the market was focusing on comments about low EU sugar prices next year.Mining stocks were putting in a mixed performance despite the strong data from top metals user China. Analysts at Citigroup said today that mining stocks could benefit from "additional short-term price momentum in the sector on positive rhetoric" following the category's underperformance so far this year compared with the UK market. "However, valuations are now looking more fully priced and we think the rally will fade into year end." The bank named Rio Tinto and Glencore Xstrata as its favoured stocks in the UK diversified mining sector, both of which were making gains today.GlaxoSmithKline declined after confirming it has reached an agreement to sell its Lucozade and Ribena brands to Japanese firm Suntory Beverage & Food for £1.35bn in cash. The company said that now is the right time to sell "as we increase the focus of our Consumer Healthcare business and execute the delivery of our late stage pipeline of pharmaceuticals and vaccines".FTSE 250: Icap and CSR lead gainsICAP is in talks about a settlement over its role in the Libor rate-rigging scandal which could see it pay about £70m ($109m) to British and US regulators, Sky News reported.Broker Liberum lited its target on CSR to buy, with a 550p price target. FTSE 100 - RisersARM Holdings (ARM) 917.50p +2.80%TUI Travel (TT.) 347.40p +2.72%Aviva (AV.) 399.80p +2.25%Burberry Group (BRBY) 1,635.00p +2.19%Lloyds Banking Group (LLOY) 76.78p +1.82%Kingfisher (KGF) 413.20p +1.67%ITV (ITV) 177.40p +1.66%Legal & General Group (LGEN) 193.80p +1.63%Whitbread (WTB) 3,216.00p +1.55%British Land Co (BLND) 557.50p +1.46%FTSE 100 - FallersBG Group (BG.) 1,217.00p -5.07%Tate & Lyle (TATE) 779.50p -3.41%Associated British Foods (ABF) 1,818.00p -1.78%Randgold Resources Ltd. (RRS) 4,914.00p -1.50%Petrofac Ltd. (PFC) 1,397.00p -1.34%Royal Dutch Shell 'A' (RDSA) 2,052.00p -1.27%Standard Chartered (STAN) 1,455.50p -1.12%United Utilities Group (UU.) 673.00p -1.10%Tullow Oil (TLW) 1,059.00p -1.03%HSBC Holdings (HSBA) 701.10p -1.02%FTSE 250 - RisersICAP (IAP) 417.80p +4.58%CSR (CSR) 517.50p +4.55%Barratt Developments (BDEV) 328.20p +4.36%888 Holdings (888) 146.90p +4.18%Enterprise Inns (ETI) 150.40p +3.72%Perform Group (PER) 523.50p +3.66%Bank of Georgia Holdings (BGEO) 1,810.00p +3.13%Debenhams (DEB) 104.50p +2.96%Halfords Group (HFD) 393.70p +2.79%Computacenter (CCC) 538.00p +2.77%FTSE 250 - FallersXaar (XAR) 760.00p -4.34%Petra Diamonds Ltd.(DI) (PDL) 122.90p -3.46%Salamander Energy (SMDR) 125.00p -3.40%Berendsen (BRSN) 906.50p -2.89%Bumi (BUMI) 211.20p -2.85%Kenmare Resources (KMR) 28.36p -2.54%Workspace Group (WKP) 430.60p -2.36%BTG (BTG) 368.00p -2.34%Brown (N.) Group (BWNG) 557.00p -2.28%Imagination Technologies Group (IMG) 287.10p -2.18%BC
More News
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.